Indivior Pharmaceuticals Inc
INDV
Classificação em ações
#4006
Indivior Pharmaceuticals Inc. operates as a holding company, primarily engaged... Indivior Pharmaceuticals Inc. operates as a holding company, primarily engaged in the research, production, and distribution of buprenorphine-based prescription medications designed to treat opioid dependence. Its product lineup features key pharmaceuticals such as Suboxone Film, Suboxone Tablet, and Subutex Tablet. The company organizes its business into several geographical regions: the United States, the United Kingdom, and the broader international market. Established on September 26, 2014, its corporate headquarters are located in North Chesterfield, Virginia.
Preço da ação
$32.56
Última sincronização: 2026-10-16
Valor de mercado
$4.06B
Variação (1 dia)
-3.15%
Variação (1 ano)
33.01%
País
US
Negociar Indivior Pharmaceuticals Inc (INDV)
Categoria
Healthcare
EPS de Indivior Pharmaceuticals Inc (INDV)
EPS em June 2026 TTM: $2.84
De acordo com os últimos relatórios financeiros e o preço das ações da Indivior Pharmaceuticals Inc, o EPS atual da empresa (TTM) é $2.84. No final de 2023, a empresa teve um EPS de $0.01, um aumento em relação a ao EPS de 2022, que foi de $-0.37.
Histórico de EPS da Indivior Pharmaceuticals Inc de 2016 até 2026
EPS no final de cada ano
| Ano | EPS | Alterar |
|---|---|---|
| 2026 (TTM) | $2.84 | 14,100.00% |
| 2024 | $0.02 | 3.42% |
| 2023 | $0.01 | -103.95% |
| 2022 | $-0.37 | -126.81% |
| 2021 | $1.38 | -227.78% |
| 2020 | $-1.08 | -213.68% |
| 2019 | $0.95 | -47.51% |
| 2018 | $1.81 | 330.95% |
| 2017 | $0.42 | 90.91% |
| 2016 | $0.22 | 0.00% |
EPS de empresas semelhantes ou concorrentes
| Empresa | EPS | Diferença de EPS | País |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| $0.56 | -80.41% |
IN
|
